| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 24.48% | Needham | → $3 | Reiterates | Buy → Buy |
| 08/11/2023 | 24.48% | Needham | → $3 | Reiterates | Buy → Buy |
| 07/10/2023 | 128.22% | JMP Securities | → $5.5 | Reiterates | Market Outperform → Market Outperform |
| 06/30/2023 | 128.22% | JMP Securities | → $5.5 | Reiterates | Market Outperform → Market Outperform |
| 05/15/2023 | 3.73% | Oppenheimer | $3.5 → $2.5 | Maintains | Outperform |
| 05/15/2023 | 128.22% | JMP Securities | $5.5 → $5.5 | Reiterates | Market Outperform → Market Outperform |
| 05/12/2023 | 24.48% | Needham | → $3 | Reiterates | Buy → Buy |
| 04/10/2023 | 128.22% | JMP Securities | $6 → $5.5 | Maintains | Market Outperform |
| 04/04/2023 | 24.48% | UBS | $4.5 → $3 | Maintains | Buy |
| 03/31/2023 | 148.96% | JMP Securities | → $6 | Reiterates | → Market Outperform |
| 03/31/2023 | 24.48% | Needham | → $3 | Reiterates | → Buy |
| 03/13/2023 | 148.96% | JMP Securities | → $6 | Reiterates | → Market Outperform |
| 01/10/2023 | 148.96% | JMP Securities | $8.5 → $6 | Maintains | Market Outperform |
| 11/15/2022 | 86.72% | UBS | $8 → $4.5 | Maintains | Buy |
| 11/07/2022 | 24.48% | Needham | $5 → $3 | Maintains | Buy |
| 08/09/2022 | 252.7% | JMP Securities | $10 → $8.5 | Maintains | Market Outperform |
| 05/10/2022 | 314.94% | JMP Securities | $13 → $10 | Maintains | Market Outperform |
| 04/07/2022 | 439.42% | JMP Securities | $14 → $13 | Maintains | Market Outperform |
| 03/25/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 03/14/2022 | 231.95% | UBS | $13 → $8 | Maintains | Buy |
| 03/11/2022 | 148.96% | Wedbush | $11 → $6 | Downgrades | Outperform → Neutral |
| 03/11/2022 | 480.91% | JMP Securities | $16 → $14 | Maintains | Market Outperform |
| 03/11/2022 | 190.46% | Needham | $11 → $7 | Maintains | Buy |
| 03/11/2022 | 128.22% | Raymond James | $11 → $5.5 | Maintains | Outperform |
| 11/12/2021 | 356.43% | Raymond James | $15 → $11 | Maintains | Outperform |
| 09/17/2021 | 439.42% | Needham | → $13 | Initiates Coverage On | → Buy |
| 09/01/2021 | 480.91% | UBS | → $14 | Initiates Coverage On | → Buy |
| 08/19/2021 | 397.93% | Wedbush | → $12 | Initiates Coverage On | → Outperform |
| 08/18/2021 | 522.41% | Raymond James | → $15 | Initiates Coverage On | → Outperform |
| 08/03/2021 | 688.38% | Oppenheimer | → $19 | Initiates Coverage On | → Outperform |
| 08/02/2021 | 563.9% | Baird | → $16 | Initiates Coverage On | → Neutral |
| 08/02/2021 | 605.39% | JMP Securities | → $17 | Initiates Coverage On | → Market Outperform |
What is the target price for Marketwise (MKTW)?
The latest price target for Marketwise (NASDAQ: MKTW) was reported by Needham on November 13, 2023. The analyst firm set a price target for $3.00 expecting MKTW to rise to within 12 months (a possible 24.48% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Marketwise (MKTW)?
The latest analyst rating for Marketwise (NASDAQ: MKTW) was provided by Needham, and Marketwise reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Marketwise (MKTW)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Marketwise, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Marketwise was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
Is the Analyst Rating Marketwise (MKTW) correct?
While ratings are subjective and will change, the latest Marketwise (MKTW) rating was a reiterated with a price target of $0.00 to $3.00. The current price Marketwise (MKTW) is trading at is $2.41, which is within the analyst's predicted range.